ISIN | LU1834886860 |
---|---|
Valor Number | 42123434 |
Bloomberg Global ID | |
Fund Name | Europe Index J EUR |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | To achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Peculiarities |
Current Price * | 303.54 EUR | 16.04.2025 |
---|---|---|
Previous Price * | 304.11 EUR | 15.04.2025 |
52 Week High * | 336.15 EUR | 03.03.2025 |
52 Week Low * | 281.53 EUR | 09.04.2025 |
NAV * | 303.54 EUR | 16.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,031,525,162 | |
Unit/Share Assets *** | 191,317,866 | |
Trading Information SIX |
YTD Performance | +0.64% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
---|---|---|
YTD Performance (in CHF) | -0.76% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
1 month | -7.67% |
17.03.2025 - 16.04.2025
17.03.2025 16.04.2025 |
3 months | -1.93% |
16.01.2025 - 16.04.2025
16.01.2025 16.04.2025 |
6 months | -1.49% |
16.10.2024 - 16.04.2025
16.10.2024 16.04.2025 |
1 year | +4.50% |
16.04.2024 - 16.04.2025
16.04.2024 16.04.2025 |
2 years | +14.42% |
17.04.2023 - 16.04.2025
17.04.2023 16.04.2025 |
3 years | +21.04% |
19.04.2022 - 16.04.2025
19.04.2022 16.04.2025 |
5 years | +23.48% |
14.06.2021 - 16.04.2025
14.06.2021 16.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.41% | |
---|---|---|
Nestle SA | 2.32% | |
ASML Holding NV | 2.26% | |
Roche Holding AG | 2.02% | |
AstraZeneca PLC | 1.97% | |
Shell PLC | 1.95% | |
Novo Nordisk AS Class B | 1.92% | |
Novartis AG Registered Shares | 1.91% | |
HSBC Holdings PLC | 1.77% | |
Siemens AG | 1.52% | |
Last data update | 31.03.2025 |
TER *** | 0.161% |
---|---|
TER date *** | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.10% |
Ongoing Charges *** | 0.17% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |